Condition: Mitral Valve Regurgitation (Degenerative or Functional) · Sponsor: Edwards Lifesciences
Study to evaluate the safety and performance of the INNOVALVE system
This description comes directly from the study's public registry record.
TMTT Clinical · (949) 250-2500 · TMTT_Clinical@edwards.com
Always discuss trial participation with your own doctor first.
| Cedars-Sinai | Los Angeles, California, United States | Recruiting |
| Stanford University | Palo Alto, California, United States | Recruiting |
| Naples Comprehensive Health | Naples, Florida, United States | Recruiting |
| Emory University | Atlanta, Georgia, United States | Recruiting |
| Piedmont Heart Institute | Atlanta, Georgia, United States | Recruiting |
| Northwestern | Chicago, Illinois, United States | Recruiting |
| University of Michigan Hospital and Health Systems | Ann Arbor, Michigan, United States | Recruiting |
| Mayo Clinic | Rochester, Minnesota, United States | Recruiting |
| Saint Luke's Hospital | Kansas City, Missouri, United States | Recruiting |
| Morristown Medical Center | Morristown, New Jersey, United States | Recruiting |
| Northwell Health | Manhasset, New York, United States | Recruiting |
| Cornell | New York, New York, United States | Withdrawn |
+ 8 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04919980